Show Search Form
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
ddp created | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 17 | ||||||||||
answering dept short name | Health and Social Care | ||||||||||
answering dept sort name | Health and Social Care | ||||||||||
ddp modified |
|
||||||||||
hansard heading | Coronavirus: Air Pollution | ||||||||||
house id | 1 | ||||||||||
identifier | 29887 | ||||||||||
legislature |
|
||||||||||
parliament number | 58 | ||||||||||
question first answered |
|
||||||||||
question text | To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 May 2021 to Question 496 on Coronavirus: Disease Control, whether the UK Health and Safety Laboratory has made an assessment of the potential merits of using hyrodxyl free radical air purification technologies to help stop the primary cause of covid-19 virus transmission via aerosol and water droplets; which companies provided the technology that was used in the assessments of the potential merits of those technologies that has already been undertaken by (a) SAGE and (b) Public Health England; and what the process is for third parties to be able to present to Government the potential use of their technology and credentials to support the undertaking of such assessments. | ||||||||||
session |
|
||||||||||
session number | 2 | ||||||||||
tabling member constituency | Mansfield | ||||||||||
tabling member printed |
|
||||||||||
title | House of Commons Tabled Parliamentary Question 2021/22 29887 | ||||||||||
type |
|
||||||||||
uin | 29887 | ||||||||||
version | 2 | ||||||||||
written parliamentary question type | Ordinary | ||||||||||
answer | answer | ||||||||||
creator |
|
||||||||||
publisher |
|
||||||||||
tabling member |
|